Detalhe da pesquisa
1.
PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients.
Br J Cancer
; 112(1): 95-102, 2015 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-25349974
2.
Increased MET and HGF gene copy numbers are associated with trastuzumab failure in HER2-positive metastatic breast cancer.
Br J Cancer
; 107(5): 793-9, 2012 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-22850551
3.
The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancer.
ESMO Open
; 6(2): 100078, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33735802
4.
Consequences of targeted treatments for second-line therapy.
Ann Oncol
; 21 Suppl 7: vii234-40, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20943621
5.
Corrigendum to 'The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancer': [ESMO Open Volume 6, Issue 2, April 2021, 100078].
ESMO Open
; 6(3): 100137, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34144775